Reports: ZORA Program (Slovenia): Difference between revisions
No edit summary |
m (Update categories.) |
||
| Line 1: | Line 1: | ||
<span style="display:none">forpolicymakers</span> | |||
Go back to [[Slovenia]] page | Go back to [[Slovenia]] page | ||
| Line 14: | Line 14: | ||
'''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access]. | '''Access to information:''' [https://zora.onko-i.si/publikacije/letna-porocila Click here to access]. | ||
<span style="display:none">Vulva</span> | |||
<span style="display:none">Vagina</span> | |||
<span style="display:none">Cervix</span> | |||
<span style="display:none">Uterus</span> | |||
<span style="display:none">Ovary</span> | |||
<span style="display:none">Fallopian tubes</span> | |||
<span style="display:none">Endometrium</span> | |||
<span style="display:none">dataOwner::Ljubljana Oncology Institute</span> | |||
<span style="display:none">dataOwner::ZORA Program</span> | |||
<span style="display:none">availableVariable::screening</span> | |||
<span style="display:none">availableVariable::cancer incidence|incidence</span> | |||
<span style="display:none">availableVariable::number of deaths|Mortality</span> | |||
<span style="display:none">availableVariable::causes of death</span> | |||
<span style="display:none">availableVariable::year</span> | |||
<span style="display:none">dataLevel::national level</span> | |||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | |||
Revision as of 13:50, 2 December 2025
Go back to Slovenia page
Primary purpose: To actively screen and reduce morbidity and mortality from cervical cancer in Slovenia, aiming for at least 70% coverage of women aged 20-64 through regular cervical smear examinations every three years.
Sponsor, manager or home institution: Ljubljana Oncology Institute; ZORA Program.
Type of information: The percentage of women in the target group who are screened according to the program guidelines (screening); The number of new patients in a given year; (RMV incidence rate); Mortality due to RMV; causes of death; The ratio between the number of newly detected precancerous and cancerous changes per year. Click here to learn more.
Data level: national level.
Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.
Access to information: Click here to access.
